Home / Brand archive
28 reported ongoing
36 records in this archive. Latest source date Jul 16, 2026.
FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination.
Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
Class IIIReported ongoing
Distribution: USA Nationwide
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
Class IIIReported ongoing
Distribution: USA Nationwide
Failed impurity/degradation specification: an OOS result observed in Related substance test analysis w.r.t Impurity II, Impurity III and Total impurities for 12-month stability
Class IIIReported ongoing
Distribution: USA Nationwide
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
Class IIReported ongoing
Distribution: Nationwide in the USA
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.
Class IIIReported ongoing
Distribution: USA Nationwide
Failed Impurities/Degradation Specifications: OOS result was observed during the related substance test analysis with respect to Impurity II, Impurity III and Total impurity testing for 12 Month Long-Term Stability.
Class IIIReported ongoing
Distribution: USA Nationwide
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
Class IIReported ongoing
Distribution: Nationwide in the USA
Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications
Class IIReported ongoing
Distribution: U.S.A. Nationwide
Failed Dissolution Specifications
Class IIReported ongoing
Distribution: U.S. Nationwide
Failed Dissolution Specifications
Class IIReported ongoing
Distribution: U.S. Nationwide
Failed Dissolution Specifications
Class IIReported ongoing
Distribution: U.S. Nationwide
Failed Dissolution Specifications
Class IIReported ongoing
Distribution: U.S. Nationwide
Failed Dissolution Specifications
Class IIReported ongoing
Distribution: U.S. Nationwide
Superpotent drug
Class IIReported ongoing
Distribution: Nationwide in the USA.
Failed Dissolution Specifications: low dissolution results
Class IIReported ongoing
Distribution: Nationwide in the USA
CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
Class IIReported ongoing
Distribution: US Nationwide.
CGMP Deviations: detection of N-nitroso-dimethyl-rizatriptan impurity, above the FDA recommended acceptable intake limit.
Class IIReported ongoing
Distribution: US Nationwide.
Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity was identified to be Cephalexin Glucose Adduct.
Class IIReported ongoing
Distribution: Nationwide in the USA.
Failed Impurities/Degradation Specifications An out-of-specification result was observed in the related substance test at the sixth month of stability analysis. The individual impurity was identified to be Cephalexin Glucose Adduct.
Class IIReported ongoing
Distribution: Nationwide in the USA.
CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit
Class IIReported ongoing
Distribution: Nationwide within the United States
These examples come from this result page and are not a ranking of every recall reason.
This archive contains 36 records, including 28 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product.
Compare the product, firm and lot, date, model or serial identifiers with the notice. Use the label-check guide if you need help locating an identifier.
A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall.
This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. Check source coverage and the agency's current notices.
Use monthly archives or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page.